Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986;30(4):439-44.
doi: 10.1007/BF00607957.

Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy

Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy

D Terziivanov et al. Eur J Clin Pharmacol. 1986.

Abstract

Six patients, aged 52 to 71 years, with T-tube drainage of the common bile duct and a urinary catheter after cholecystectomy, were studied in order to evaluate the urinary and biliary excretion and pharmacokinetics of cefotiam in the early postoperative period. Each patient received cefotiam 1 g i.v. as a bolus injection. Cefotiam in plasma, urine, and bile were determined by HPLC. A 2-compartment open model with elimination from the central compartment satisfactorily fitted the plasma levels of the drug. The renal clearance of cefotiam (CLR = 133 ml/min) was an order of magnitude greater than its biliary clearance (CLB = 11.8 ml/min). Glomerular filtration was the main mechanism for elimination of cefotiam. The values of CLR and CLB in relation to the total plasma clearance (CL = 138. ml/min) demonstrated the negligible role of metabolism in elimination of cefotiam in these patients.

PubMed Disclaimer

References

    1. J Pharm Sci. 1968 Jan;57(1):117-23 - PubMed
    1. J Chromatogr. 1983 Jun 10;275(1):133-44 - PubMed
    1. Antimicrob Agents Chemother. 1983 Mar;23(3):429-34 - PubMed
    1. J Antibiot (Tokyo). 1978 Jul;31(7):703-11 - PubMed
    1. Eur J Clin Pharmacol. 1983;24(4):549-56 - PubMed

LinkOut - more resources